SenesTech, Inc. — fact timeline

SenesTech, Inc. shareholders approved Ratification of M&K CPAS, PLLC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“Our stockholders ratified the appointment of M&K CPAS, PLLC as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstentions Broker Non-Votes Ratification of M&K CPAS, PLLC as our independent registered public accounting firm 2,754,180 225,124 71,038 —”

SenesTech, Inc. shareholders approved Amendment to 2018 Equity Incentive Plan to increase shares by 1,200,000 at the 2026-06-09 meeting.

“Our stockholders approved an amendment to our 2018 Equity Incentive Plan (the “2018 Plan”) to increase the number of shares of common stock available for issuance under the 2018 Plan by 1,200,000 shares (the “2018 Amended Plan”). Votes For Votes Against Abstentions Broker Non-Votes 2018 Amended Plan 1,155,241 204,833 4,760 1,685,508”

SenesTech, Inc. shareholders approved Non-binding advisory vote on compensation of named executive officers for fiscal 2025 at the 2026-06-09 meeting.

“Our stockholders approved, on a non-binding advisory basis, the compensation of our named executive officers for fiscal 2025 (“Say-on-Pay”). Votes For Votes Against Abstentions Broker Non-Votes Say-on-Pay Proposal 1,184,641 122,408 57,785 1,685,508”

SenesTech, Inc. shareholders approved Election of Class I Directors at the 2026-06-09 meeting.

“Our stockholders elected the individuals listed below as a Class I directors at the Annual Meeting, each to serve for a three-year term until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified . Director Votes For Votes Withheld Broker Non-Votes Jake S. Leach 1,293,056 71,778 1,685,508 Joshua M. Moss 1,319,573 45,261 1,685,508”

SenesTech, Inc. reported first quarter ended March 31, 2026 results: revenue $493,000.

“Q1 2026 Financial Highlights • Revenue increased 2% to $493,000 in Q1 2026 compared to $485,000 in Q1 2025, despite approximately $157,000 of reduced third-party e-commerce revenue associated with the Company’s transition from third-party e-commerce management to in-house management of Amazon sales.”

Michael Edell was appointed as Class III director at SenesTech, Inc..

“On May 6, 2026, Mr. Edell was also appointed as a member of the Board, and will serve as a Class III director of the Board”

Michael Edell was appointed as President and Chief Executive Officer at SenesTech, Inc..

“appointed Michael Edell as the Company’s President and Chief Executive Officer”

Joel L. Fruendt departed as President and Chief Executive Officer at SenesTech, Inc..

“succeeding Mr. Joel L. Fruendt, the current President and Chief Executive Officer of the Company.”

SenesTech, Inc. reported Full year ended December 31, 2025 results: net income $6.4 million.

“Revenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company’s overall e-commerce channels despite the impact associated with the Company’s transition to directly managing Amazon sales of Evolve ® Rat and Evolve Mouse.”

Joshua M. Moss was appointed as Director at SenesTech, Inc..

“On January 8, 2025, our Board of Directors (the “Board”) authorized an increase in the size of the Board to six members and appointed Joshua M. Moss to serve on the Board as an independent director.”

SenesTech, Inc. reported first quarter ended March 31, 2024 results: revenue $415,000, net income $1.8 million.

“EPA-registered Rat Birth Control ® products today announced financial results for the first quarter of 2024. Recent Highlights • Record quarterly revenues during Q1 2024 of $415,000, an increase of 78% compared to Q1 2023. • EvolveTM, formulated especially for the control of rat fertility and launched at the beginning of the year, has quickly become the”

SenesTech, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“February 26, 2024, we received notice from Nasdaq indicating that, while we have not regained compliance with the Rule, the Staff has determined that we are eligible for an additional 180 calendar day period, or until August 19, 2024, to regain compliance. The Staff’s determination was based on (i) our meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and (ii) our providing written notice to Nasdaq of our intent to cure the de”

SenesTech, Inc. reported financial results for the fourth quarter and fiscal year ended December 31, 2023.

“On February 21, 2024, we announced our financial results for the fourth quarter and fiscal year ended December 31, 2023. A copy of our press release announcing these financial results and certain other information is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.”

SenesTech, Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(4)).

“November 20, 2023, we received a letter from the listing qualifications staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) providing notification that we no longer meet the minimum 500,000 publicly held shares requirement pursuant to Nasdaq Listing Rule 5550(a)(4). As a result of our previously announced 1-for-12 reverse stock split of our common stock, the aggregate number of our outstanding shares of common stock was reduced from 5,899,060 shares on a pre-reverse-split basis to a total of 492,293 shares outstanding on a post-reverse split basis. In accordance with Nasdaq rules, we hav”

SenesTech, Inc.: Filed an amendment to the Certificate of Incorporation to effect a 1-for-12 reverse stock split, effective 4:01 p.m. ET on November 16, 2023 (effective 2023-11-16).

“On November 7, 2023, our Reverse Split Committee of our Board of Directors approved a final split ratio of one-for-twelve (1:12). Following such approval, we filed an amendment to the Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware on November 14, 2023 to effect the reverse stock split, with an effective time of 4:01 p.m., Eastern Time on November 16, 2023.”

SenesTech, Inc. reported the third quarter ended September 30, 2023 results: revenue $360,000, net income $1.9 million.

“will dramatically increase the adoption of the Evolve solution and to set SenesTech up for tremendous success in the future.” Q3 2023 Highlights • Revenue during Q3 2023 was $360,000 compared to $250,000 in Q3 2022, an increase of 44%. • Gross profit during Q3 2023 was $176,000, for a gross profit margin of 49%, compared to $122,000, or a gross profit margin”

SenesTech, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“August 25, 2023, we received a letter from the listing qualifications staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) providing notification that the bid price for our common stock had closed below $1.00 per share for the previous 30 consecutive business days and our common stock no longer meets the minimum bid price requirement for continued listing under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have an initial period of 180 calendar days, or until February 21, 2024, to regain compliance. To regain compliance, the closing bid price of”

SenesTech, Inc. entered into Inducement Letter with a certain holder of certain of our existing warrants valued at $2,113,480.92 (effective 2023-08-21).

“On August 21, 2023, we entered into an inducement offer letter agreement (the “Inducement Letter”) with a certain holder (the “Holder”) of certain of our existing warrants”

SenesTech, Inc. shareholders approved Adjournment of the Special Meeting to a later date if necessary to permit further solicitation and vote of proxies due to insufficient votes for Reverse Stock Split Proposal at the 2023-08-18 meeting.

“Our stockholders approved an adjournment of the Special Meeting, to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal (the “Adjournment Proposal”) . The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes Adjournment Proposal 1,438,385 294,752 11,855 —”

SenesTech, Inc. shareholders approved Amendment to Amended and Restated Certificate of Incorporation to effect a reverse stock split of outstanding shares of common stock, by a ratio of not less than 1-for-2 and not more than 1-for-12, with exact ratio set by the Board at the 2023-08-18 meeting.

“Our stockholders approved an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the outstanding shares of our common stock, by a ration of not less that 1-for-2 and not more than 1-for-12 shares, with the exact ratio to be set at a whole number within this range by our Board of Directors in its sole discretion (the “Reverse Stock Split Proposal”). The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes Reverse Stock Split Proposal 1,358,353 383,057 3,582 —”

SenesTech, Inc. reported second quarter ended June 30, 2023 results: net income Net loss during Q2 2023 was $2.0 million, compared with a net loss of $2.6 million for Q2 2022..

“Revenue during Q2 2023 was $305,000 compared to $277,000 in Q2 2022.”

SenesTech, Inc. shareholders approved Ratification of M&K CPAS, PLLC as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-26 meeting.

“Our stockholders ratified the appointment of M&K CPAS, PLLC as our independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes For Votes Against Abstentions Broker Non-Votes Ratification of M&K CPAS, PLLC as our independent registered public accounting firm 1,819,313 63,155 77,467 —”

SenesTech, Inc. shareholders approved Amendment to 2018 Plan to increase shares available by 500,000 shares at the 2023-06-26 meeting.

“Our stockholders approved an amendment to our 2018 Plan to increase the number of shares available for issuance under the 2018 Plan by 500,000 shares (the “2018 Plan Amendment”). Votes For Votes Against Abstentions Broker Non-Votes 2018 Plan Amendment 609,140 216,854 6,872 1,127,069”

SenesTech, Inc. shareholders approved Non-binding advisory vote on compensation of named executive officers for fiscal 2022 at the 2023-06-26 meeting.

“Our stockholders approved, on a non-binding advisory basis, the compensation of our named executive officers for fiscal 2022 (“say-on-pay”). Votes For Votes Against Abstentions Broker Non-Votes Say-on-pay proposal 536,520 145,570 150,776 1,127,069”

SenesTech, Inc. shareholders approved Election of Jake S. Leach as a Class I director at the 2023-06-26 meeting.

“The Annual Meeting was held in Phoenix, Arizona on June 26, 2023. At the Annual Meeting, our stockholders voted on the following proposals and cast their votes as described below. Our stockholders elected the individual listed below as a Class I director at the Annual Meeting, to serve for a three-year term until the 2026 annual meeting of stockholders and until his successor is duly elected and qualified . Director Votes For Votes Withheld Broker Non-Votes Jake S. Leach 432,429 345,532 1,127,069”

SenesTech, Inc. reported first quarter ended March 31, 2023 results: revenue $233,000, net income $2.0 million.

“Revenue during Q1 2023 was $233,000 compared to $195,000 in Q1 2022, an increase of 19%. • Gross profit during Q1 2023 was $92,000, for a gross profit margin of 39.6%, compared to $90,000, or a gross profit margin of 46.2%, in Q1 2022. Excluding costs related to the scrapping of defective inventory no longer used in our products, gross profit margin was 57.8% in Q1 2023. • Net loss during Q1 2023 was $2.0 million, compared with a net loss of $2.3 million for Q1 2022.”

Nicole Williams was terminated as Chief Revenue Officer at SenesTech, Inc..

“On April 20, 2023, Nicole Williams’ employment with our company terminated.”

SenesTech, Inc. entered into Securities Purchase Agreement with H.C. Wainwright & Co., LLC valued at aggregate proceeds of approximately $1.5 million; 857,146 shares of common stock at $1.75 per share (effective 2023-04-10).

“On April 10, 2023, we entered into a Securities Purchase Agreement (the “Purchase Agreement”), pursuant to which we agreed to sell and issue in a registered direct offering (the “Registered Direct Offering”) an aggregate of 857,146 shares of our common stock (the “Shares”) and, in a concurrent private placement (the “Private Placement” and together with the Registered Direct Offering, the “Offerings”), unregistered warrants to purchase up to 857,146 shares of common stock (“Series C Warrants”), at an offering price of $1.75 per Share and associated Series C Warrant.”

SenesTech, Inc. reported the fourth quarter and fiscal year ended December 31, 2022 results: revenue $1.0 million, net income $9.7 million.

“, although we reserve the right to discontinue the availability at any time. --- EX-99.1 (EX-99.1) --- SenesTech Announces 2022 Financial Results Product Sales Break $1 Million Sales Increase 77% for the Year PHOENIX, Ariz., March 16, 2023. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), ( www.senestech.com ) the rodent fertility control”

Nicole Williams was appointed as Chief Revenue Officer at SenesTech, Inc..

“On February 15, 2023, we appointed Nicole Williams as Chief Revenue Officer.”

Kenneth Siegel resigned as Director at SenesTech, Inc..

“Mr. Siegel also resigned from his position as a director of our company effective as of December 31, 2022”

Kenneth Siegel retired as Chief Executive Officer at SenesTech, Inc..

“In connection with the previously announced retirement of Kenneth Siegel, our former Chief Executive Officer”

Joel Fruendt was appointed as Director at SenesTech, Inc..

“Mr. Fruendt was also appointed as a member of our Board of Directors, effective as of the Commencement Date.”

Joel Fruendt was appointed as Chief Executive Officer at SenesTech, Inc..

“On November 14, 2022, Joel Fruendt was appointed as Chief Executive Officer of our company, effective as of November 15, 2022”

Kenneth Siegel departed as Director at SenesTech, Inc..

“and is expected to retire as a director on December 31, 2022.”

Kenneth Siegel departed as Chief Executive Officer at SenesTech, Inc..

“Mr. Siegel’s retirement as our Chief Executive Officer will be effective November 15, 2022.”

K.C. Kavanagh resigned as Director at SenesTech, Inc..

“On August 30, 2022, K.C. Kavanagh notified us of her intention to resign as a member of our Board of Directors, effective September 1, 2022.”

Steve Krause changed role as Executive Vice President, Sales and Marketing at SenesTech, Inc..

“Mrs. Williams expanded role coincides with Steve Krause’s transition from his role as Executive Vice President, Sales and Marketing overseeing SenesTech’s sales and marketing function to a non-executive role where Mr. Krause will focus on the continued evolution and expansion of the Company’s agricultural market and distributor channel.”

Nicole Williams changed role as Chief Strategy Officer at SenesTech, Inc..

“On January 1, 2022, Nicole Williams’ responsibilities as the Company’s Chief Strategy Officer expanded to include the oversight of the Company’s marketing and sales operations.”